Literature DB >> 23748873

Perceived versus predicted risks of colorectal cancer and self-reported colonoscopies by members of mismatch repair gene mutation-carrying families who have declined genetic testing.

Louisa Flander1, Andrew Speirs-Bridge, Alison Rutstein, Heather Niven, Aung Ko Win, Driss Ait Ouakrim, John L Hopper, Finlay Macrae, Louise Keogh, Clara Gaff, Mark Jenkins.   

Abstract

People carrying germline mutations in mismatch repair genes are at high risk of colorectal cancer (CRC), yet about half of people from mutation-carrying families decline genetic counselling and/or testing to identify mutation status. We studied the association of quantitative measures of risk perception, risk prediction and self-reported screening colonoscopy in this elusive yet high-risk group. The sample of 26 participants (mean age 43.1 years, 14 women) in the Australasian Colorectal Cancer Family Registry were relatives of mutation carriers; had not been diagnosed with any cancer at the time of recruitment and had declined an invitation to attend genetic counselling and/or testing. A structured elicitation protocol captured perceived CRC risk over the next 10 years. Self-reported colonoscopy screening was elicited during a 45-minute semi-structured interview. Predicted 10-year CRC risk based on age, gender, known mutation status and family history was calculated using "MMRpro." Mean perceived 10-year risk of CRC was 31 % [95 % CI 21, 40], compared with mean predicted risk of 4 % [2, 7] (p < 0.001); this was independent of age and sex (p = 0.9). Among those reporting any medical advice and any screening colonoscopy (n = 18), those with higher risk perception had less frequent colonoscopy (Pearson's r = 0.49 [0.02, 0.79]). People who decline genetic testing for CRC susceptibility mutations perceive themselves to be at substantially higher risk than they really are. Those with high perceived risk do not undertake screening colonoscopy more often than those who perceive themselves to be at average risk.

Entities:  

Mesh:

Year:  2013        PMID: 23748873      PMCID: PMC3838501          DOI: 10.1007/s10897-013-9614-2

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  45 in total

1.  Relatives of colorectal cancer patients: factors associated with screening behavior.

Authors:  Lisa Madlensky; Mary Jane Esplen; Steven Gallinger; John R McLaughlin; Vivek Goel
Journal:  Am J Prev Med       Date:  2003-10       Impact factor: 5.043

Review 2.  Probability information in risk communication: a review of the research literature.

Authors:  Vivianne H M Visschers; Ree M Meertens; Wim W F Passchier; Nanne N K de Vries
Journal:  Risk Anal       Date:  2008-11-05       Impact factor: 4.000

3.  Changes in risk perceptions in relation to self-reported colorectal cancer screening among first-degree relatives of colorectal cancer cases enrolled in a randomized trial.

Authors:  Beth A Glenn; Alison K Herrmann; Catherine M Crespi; Cynthia M Mojica; L Cindy Chang; Annette E Maxwell; Roshan Bastani
Journal:  Health Psychol       Date:  2011-07       Impact factor: 4.267

4.  Prediction of germline mutations and cancer risk in the Lynch syndrome.

Authors:  Sining Chen; Wenyi Wang; Shing Lee; Khedoudja Nafa; Johanna Lee; Kathy Romans; Patrice Watson; Stephen B Gruber; David Euhus; Kenneth W Kinzler; Jeremy Jass; Steven Gallinger; Noralane M Lindor; Graham Casey; Nathan Ellis; Francis M Giardiello; Kenneth Offit; Giovanni Parmigiani
Journal:  JAMA       Date:  2006-09-27       Impact factor: 56.272

5.  Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer.

Authors:  Polly A Newcomb; John Baron; Michelle Cotterchio; Steve Gallinger; John Grove; Robert Haile; David Hall; John L Hopper; Jeremy Jass; Loïc Le Marchand; Paul Limburg; Noralane Lindor; John D Potter; Allyson S Templeton; Steve Thibodeau; Daniela Seminara
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-11-02       Impact factor: 4.254

6.  Value of database linkage: are patients at risk of familial colorectal cancer being referred for genetic counselling and testing?

Authors:  C Wong; P Gibbs; J Johns; I Jones; I Faragher; E Lynch; F Macrae; L Lipton
Journal:  Intern Med J       Date:  2007-10-03       Impact factor: 2.048

7.  Colorectal cancer screening among first-degree relatives of colorectal cancer patients: benefits and barriers.

Authors:  Lloyd A Mack; Linda S Cook; Walley J Temple; Linda E Carlson; Robert J Hilsden; Elizabeth Oddone Paolucci
Journal:  Ann Surg Oncol       Date:  2009-05-29       Impact factor: 5.344

8.  An advance notification letter increases participation in colorectal cancer screening.

Authors:  S R Cole; A Smith; C Wilson; D Turnbull; A Esterman; G P Young
Journal:  J Med Screen       Date:  2007       Impact factor: 2.136

9.  Risk perception among Brazilian individuals with high risk for colorectal cancer and colonoscopy.

Authors:  Erika M Santos; Maria Tc Lourenço; Benedito M Rossi
Journal:  Hered Cancer Clin Pract       Date:  2011-07-28       Impact factor: 2.857

10.  Knowledge about hereditary nonpolyposis colorectal cancer; mutation carriers and physicians at equal levels.

Authors:  Katarina Domanska; Christina Carlsson; Pär-Ola Bendahl; Mef Nilbert
Journal:  BMC Med Genet       Date:  2009-03-26       Impact factor: 2.103

View more
  6 in total

1.  Choosing not to undergo predictive genetic testing for hereditary colorectal cancer syndromes: expanding our understanding of decliners and declining.

Authors:  Louise A Keogh; Heather Niven; Alison Rutstein; Louisa Flander; Clara Gaff; Mark Jenkins
Journal:  J Behav Med       Date:  2017-02-14

2.  Cohort Profile: The Colon Cancer Family Registry Cohort (CCFRC).

Authors:  Mark A Jenkins; Aung Ko Win; Allyson S Templeton; Maggie S Angelakos; Daniel D Buchanan; Michelle Cotterchio; Jane C Figueiredo; Stephen N Thibodeau; John A Baron; John D Potter; John L Hopper; Graham Casey; Steven Gallinger; Loic Le Marchand; Noralane M Lindor; Polly A Newcomb; Robert W Haile
Journal:  Int J Epidemiol       Date:  2018-04-01       Impact factor: 7.196

3.  Discussions about predictive genetic testing for Lynch syndrome: the role of health professionals and families in decisions to decline.

Authors:  Anaita Kanga-Parabia; Clara Gaff; Louisa Flander; Mark Jenkins; Louise A Keogh
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

4.  The Impact of Receiving Predictive Genetic Information about Lynch Syndrome on Individual Colonoscopy and Smoking Behaviors.

Authors:  Joanne Soo-Min Kim; Peter C Coyte; Michelle Cotterchio; Louise A Keogh; Louisa B Flander; Clara Gaff; Audrey Laporte
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-08-15       Impact factor: 4.254

Review 5.  Does colorectal cancer risk perception predict screening behavior? A systematic review and meta-analysis.

Authors:  Thomas M Atkinson; Talya Salz; Kaitlin K Touza; Yuelin Li; Jennifer L Hay
Journal:  J Behav Med       Date:  2015-08-18

6.  Uptake and predictors of colonoscopy use in family members not participating in cascade genetic testing for Lynch syndrome.

Authors:  Donald W Hadley; Dina Eliezer; Yonit Addissie; Andrea Goergen; Sato Ashida; Laura Koehly
Journal:  Sci Rep       Date:  2020-09-29       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.